Skip to content

Quick ratio at other companies

Pfizer logo
PfizerPFE
1.2×0.0×
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
4.3×+0.6×
PTC Therapeutics logo
PTC TherapeuticsPTCT
2.4×-1.5×
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
8.9×-12.7×
Vericel logo
VericelVCEL
4.8×+0.2×
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
19.9×-0.4×

Other financials

Income statement

See full
Revenue--100%
Operating income-$36.8M-47.2%
Net income-$33.9M-39.2%
EPS (diluted)-$0.59-11.3%

Balance sheet

See full
Cash & equivalents$105.4M+266%
Total debt$14.8M+1,083%
Total equity$278.7M+118%
Total assets$326.3M+112%

Cash flow

See full
Operating cash flow-$29.3M-355%
CapEx$5.1M+472%
Free cash flow-$34.4M-369%

Valuation

See full
Market cap$1.71B+303%

Profitability

See full
Operating margin-778.8%-1,038pp
Net margin-736.6%-981pp
FCF margin-563.9%-954pp

Returns & leverage

See full
Return on equity-56.4%-11.3pp
Debt / equity0.1×0.0×
Current ratio8.4×+1.9×

Where this comes from

Calculated from Capricor Therapeutics’s reported figures.

Based on the most recent quarter.

The official record: Capricor Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Capricor Therapeutics's quick ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Capricor Therapeutics's quick ratio?
Capricor Therapeutics (CAPR) reported quick ratio of 8.4× in Q1 2026.
How has Capricor Therapeutics's quick ratio changed year-over-year?
Capricor Therapeutics's quick ratio increased by 28.5% year-over-year, from 6.5× to 8.4×.
What is the long-term trend for Capricor Therapeutics's quick ratio?
Over 5 years (2020 to 2025), Capricor Therapeutics's quick ratio has grown at a -4.5% compound annual growth rate (CAGR), from 11.3× to 9×.
What does quick ratio mean?
Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.